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Abstract
Background: In contrast to other agents able to induce apoptosis of cultured cells, Ca2+ ionophore A23187 was
shown to elicit direct activation of intracellular signal(s). The phenotype of the cells derived from patients having
the hemorrhagic disease Scott syndrome, is associated with an abnormally high proportion of apoptotic cells, both
in basal culture medium and upon addition of low ionophore concentrations in long-term cultures. These features
are presumably related to the mutation also responsible for the defective procoagulant plasma membrane
remodeling. We analyzed the specific transcriptional re-programming induced by A23187 to get insights into the
effect of this agent on gene expression and a defective gene regulation in Scott cells.
Results: The changes in gene expression upon 48 hours treatment with 200 nM A23187 were measured in Scott
B lymphoblasts compared to B lymphoblasts derived from the patient's daughter or unrelated individuals using
Affymetrix microarrays. In a similar manner in all of the B cell lines, results showed up-regulation of 55 genes, out
of 12,000 represented sequences, involved in various pathways of the cell metabolism. In contrast, a group of 54
down-regulated genes, coding for histones and proteins involved in the cell cycle progression, was more
significantly repressed in Scott B lymphoblasts than in the other cell lines. These data correlated with the
alterations of the cell cycle phases in treated cells and suggested that the potent effect of A23187 in Scott B
lymphoblasts may be the consequence of the underlying molecular defect.
Conclusion: The data illustrate that the ionophore A23187 exerts its pro-apoptotic effect by promoting a
complex pattern of genetic changes. These results also suggest that a subset of genes participating in various steps
of the cell cycle progress can be transcriptionally regulated in a coordinated fashion. Furthermore, this research
brings a new insight into the defect in cultured Scott B lymphoblasts, leading to hypothesize that a mutated gene
plays a role not only in membrane remodeling but also in signal transduction pathway(s) leading to altered
transcriptional regulation of cell cycle genes.
Published: 21 October 2005
BMC Genomics 2005, 6:146 doi:10.1186/1471-2164-6-146
Received: 14 June 2005
Accepted: 21 October 2005
This article is available from: http://www.biomedcentral.com/1471-2164/6/146
© 2005 Kozian et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
Page 2 of 12
(page number not for citation purposes)
Background
Several signaling pathways have been identified which
promote the characteristic features of apoptotic cell death,
including cell shrinkage, translocation of phosphatidyl-
serine from the inner to the outer leaflet of the plasma
membrane, internucleosomal DNA fragmentation and
budding leading to disintegration into apoptotic bodies
[1-3]. The biochemical and cellular mechanisms involved
depend on the apoptogenic stimulus and may also be spe-
cific to the experimental model [4]. In contrast to other
agents able to induce apoptosis, Ca2+ ionophore A23187
elicits direct activation of intracellular signal(s). A23187
provokes caspase-independent apoptosis in Jurkat cells,
which differs from Fas cross-linking by antibodies [3].
However, the apoptotic pathways induced by A23187,
dependent on extracellular Ca2+ ions [5,6], remain a mat-
ter of debate [7]. Although the effect of A23187 on gene
transcription had been documented for various genes,
there were no experimental data available on the overall
pattern of gene expression in cells grown in the presence
of this agent.
Scott syndrome is an extremely rare hereditary defect of
swift egress (scrambling) of phosphatidylserine to the cell
surface of stimulated platelets and blood cells, when chal-
lenged by stimuli resulting in rapid elevation of cytosolic
Ca2+ concentration [8-10], and the clinical phenotype is
hemorrhagic [9]. Functional studies performed with B
lymphocytes immortalized by Epstein-Barr virus (EBV)-
transformation (B lymphoblasts) derived from three
unrelated Scott syndrome patients demonstrated the same
deficiency of rapid membrane response and suggested
alteration in (a) Ca2+-dependent transduction pathway(s)
[11-15]. Another characteristic of cultured Scott B lym-
phoblasts is a spontaneous tendency to apoptosis that is
enhanced when A23187 is added to the culture medium
[12,13,16,17]. We previously demonstrated using several
methods that addition of 200 nM A23187 for 48 hours in
the culture medium induced apoptosis in Scott B lym-
phoblasts more markedly than observed in control B cell
lines [16]. It has been currently observed that cells origi-
nating from patients with genetic diseases or acquired
pathologies may exhibit either spontaneous susceptibility
or resistance to apoptosis, allowing the study of the role of
the defective genes in the corresponding apoptotic proc-
esses [18-20]. The Scott B lymphoblasts thus appeared to
constitute a unique model for the global investigation of
changes in gene expression patterns during apoptosis and
search of mutation(s) possibly accounting for the hemor-
rhagic phenotype associated with the syndrome.
In order to understand what controls the apoptogenic
potential of the ionophore we examined by DNA micro-
array analysis whether A23187 provoked changes in the
transcriptional patterns for 12,000 different mRNA
sequences. We simultaneously checked if differential
modulation of gene expression could account for the
enhanced susceptibility of Scott B lymphoblasts to apop-
tosis as compared to B lymphoblasts derived from the
patient's daughter or unrelated individuals. A change of
expression of 109 genes was observed, including the coor-
dinated repression of a set of 54 genes mostly involved in
cell cycle progress. Our data illustrated that A23187-
induced apoptosis correlates with transcriptional regula-
tion of multiple genes and that global profiling analyses
are important approaches for a better understanding of
the involved mechanism(s). The results also showed a
more pronounced gene repression in Scott B lymphob-
lasts, suggesting that the defect implies an element
involved in (a) signal transduction pathway(s) promoting
A23187-induced transcriptional regulation of cell cycle
genes.
Results
Apoptotic characteristics of Scott B lymphoblasts
Spontaneous cell mortality of Scott B lymphoblasts in
vitro has been previously shown [13,17] as well as their
high susceptibility to 200 nM Ca2+ ionophore A23187-
induced apoptosis [16]. We confirmed using the cells cul-
tured for the present study, the apoptogenic effect of the
treatment for all B lymphoblasts (Table 1) and the much
higher amount of apoptotic Scott B lymphoblasts in basal
medium and upon addition of A23187.
Identification of 109 genes that are transcriptionally 
modulated in B lymphoblasts cultured in the presence of 
A23187
The selection criteria for analyses of the hybridization
data as defined in the Methods section enabled identifica-
tion of 109 genes that were differentially expressed with a
two-fold change or more of gene expression, after treat-
ment of B lymphoblasts with 200 nM Ca2+ ionophore
A23187 for 48 hours [see Additional file 1]. Hierarchical
clustering [21] (Fig. 1) and comparison of the fold change
Table 1: Effect of A23187 on apoptosis. The B lymphoblasts were 
cultured in basal (X-VIVO15) medium in the absence or presence 
of 200 nM A23187 for 48 hours. Percentages of FITC-annexinV 
positive cells were determined as described in Methods. Two 
Scott B lymphoblasts independently immortalized from the 
patient's lymphocytes, one daughter's and two control B 
lymphoblasts from unrelated individuals were used for these 
studies. Each cell line was analyzed twice. Results are means ± SD 
from the four experiments for Scott and control B lymphoblasts 
respectively and the two experiments for daughter's cells.
% of annexin V positive cells
untreated + A23187
Control 18.5 ± 10.7 33.7 ± 17.6
Daughter 14.9 ± 8.6 29.6 ± 0.3
Scott 48.7 ± 7.6 64.7 ± 12.9BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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Cluster analysis to compare the fold changes in gene expression in cells treated by A23187 Figure 1
Cluster analysis to compare the fold changes in gene expression in cells treated by A23187. Cluster analysis 
allowed to directly compare the fold changes in gene expression for each one the three cell lines respectively (C: control B 
lymphoblasts; D: daughter's B lymphoblasts; S: Scott B lymphoblasts). Ratios determining the fold changes in gene expression 
due to treatment for 48 hours with 200 nM A23187 were examined for each one of the three cell types. The hierachical clus-
tering of the selected genes (fold change of gene expression >2 with a P-value of <0.02 in at least one of the three cell types, 
see additional file 1) was performed. Without changing their respective hierarchical order, the genes were then grouped by 
functional category. Differential gene expression in A23187-treated versus non-treated cells is color coded as indicated at the 
bottom of the figure (fold-changes < 0.5 [see Additional file 1] correspond here to <-1/0.5, i.e. <-2). (A) Cluster analysis of up-
regulated genes. (B) Cluster analysis of down-regulated genes. For selected genes represented on the U95Av2 GeneChips by 
more than one Probe Set ID [see Additional file 1], data corresponding to a single Probe Set ID were used for the cluster anal-
ysis and the gene lists in Tables 2 and 3.BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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Table 2: Fold change of induced gene expression in B lymphoblasts treated with ionophore A23187. Genes listed here showed a 2-fold 
increase or more in gene expression in at least one of the three B lymphoblasts cultured for 48 h with 200 nM A23187. Data are fold 
changes calculated from hybridization values in treated versus non treated cells for each one of the B lymphoblasts respectively (see 
additional file 1). For each functional group, the genes were ordered by using a program for gene clustering. *Genes basally expressed 
differently in the cell lines (see additional file 2).
Accession no. control daughter's Scott Gene definition
Chemokines
D90144 2.05 2.79 1.80 LD78 alpha
M26383 12.28 15.78 8.70 MONAP
D43768 11.58 30.28 11.87 SCM-1*
NM002984 5.46 8.43 4.63 SCYA4
U83171 9.70 2.44 2.29 macrophage-derived chemokine*
U02020 3.79 4.71 3.37 PBEF
X13274 4.19 3.20 9.17 IFN-gamma
D12614 2.83 3.91 3.01 TNF-beta
Cell proliferation
AB044548 7.36 1.83 1.77 P/OKcl.6*
X79067 2.40 1.98 1.56 ERF-1
X59892 4.29 4.83 4.71 IFN-inducible gamma 2
AB021663 7.95 12.89 5.23 leucine-zipper protein
D84224 7.47 10.92 7.44 methionyl tRNA synthetase
X52560 4.32 4.10 3.70 NF-IL6
AF064105 3.44 3.00 2.67 Cdc14B3 phosphatase
AF022375 2.86 2.22 2.63 VEGF
X77366 2.66 2.51 2.42 HBZ17
M91196 2.02 3.70 3.47 DNA-binding protein
J04076 3.67 3.88 3.41 EGR2
U09587 2.01 2.13 2.20 glycyl-tRNA synthetase
U12767 3.84 4.00 7.02 MINOR
U27655 3.70 1.76 3.60 RGP3
U88964 -1.14 1.14 2.57 HEM45*
D87116 1.67 1.79 2.71 MAP kinase kinase 3b
Metabolism
U08997 2.03 2.41 1.82 glutamate dehydrogenase
X01630 12.51 17.87 15.17 argininosuccinate synthetase
M55543 6.11 4.96 4.47 GPB-2*
M37721 2.20 2.27 2.77 peptidylglycine alpha-amidating monooxygenase
AF081195 2.48 3.98 2.18 CalDAG-GEFII
U53347 2.05 2.21 2.25 neutral amino acid transporter B
M77836 2.86 3.08 2.36 pyrroline 5-carboxylate reductase
X05908 2.18 3.45 2.77 Lipocortin*
X92720 2.05 2.10 2.34 phosphoenolpyruvate carboxykinase
AK000379 2.82 2.91 3.10 similar to asparagine synthetase
X76488 2.43 2.48 2.44 lysosomal acid lipase*
S52784 3.36 3.86 4.85 cystathionine gamma-lyase
U26398 1.98 3.69 2.77 inositol polyphosphate 4-phosphatase
AF002020 1.03 1.33 3.00 Niemann-Pick C disease protein
M11233 1.23 1.21 3.59 cathepsin D*
Metallothionein family
M13003 2.85 10.83 1.90 metallothionein-I F*
K01383 3.62 4.60 3.90 metallothionein-I A
D13365 2.74 2.46 2.36 GIF
X64177 1.91 2.79 1.82 metallothionein
M10942 1.93 2.49 2.17 metallothionein-I E
Micellaneous
M31516 5.63 4.00 3.57 decay-accelerating factor
D90224 4.84 3.93 2.16 GP 34*
M27492 2.28 3.60 3.07 IL-1 receptor*
AF104032 2.43 3.06 2.83 LAT1
X03444 2.79 2.02 3.66 lamin A*
U33017 1.90 2.62 1.56 SLAM
U16954 1.97 2.35 2.81 AF1q*BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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U64863 4.14 4.57 3.41 PD-1*
Y14039 2.25 3.48 2.51 CASH alpha*
U76248 2.47 2.81 2.68 SIAH2
M80899 2.13 1.33 2.69 AHNAK*
Table 2: Fold change of induced gene expression in B lymphoblasts treated with ionophore A23187. Genes listed here showed a 2-fold 
increase or more in gene expression in at least one of the three B lymphoblasts cultured for 48 h with 200 nM A23187. Data are fold 
changes calculated from hybridization values in treated versus non treated cells for each one of the B lymphoblasts respectively (see 
additional file 1). For each functional group, the genes were ordered by using a program for gene clustering. *Genes basally expressed 
differently in the cell lines (see additional file 2). (Continued)
values (Tables 2 and 3), showed one group of 55 genes
characterized by transcriptional activation (Fig. 1A, Table
2) and another group of 54 genes by repressed transcrip-
tion (Fig. 1B, Table 3).
Up-regulation of 55 genes
The activation of transcription for each one of the 55 up-
regulated genes respectively appeared to be mostly of
comparable amplitude in the three Scott, daughter's and
control B lymphoblasts cell lines. These genes belong to
various functional categories, coding for cytokines, tran-
scription or growth factors and proteins of cell metabo-
lism (Fig. 1A, Table 2). Hybridization ratios comparing
the expression levels, in the absence of A23187, in Scott
and daughter's relative to the control B lymphoblasts [see
Additional file 2], suggested that in some cases, such as for
expression of SCM-1 or macrophage-derived chemokine,
different up-regulation values for a given gene reflected
variable basal expression. The effect of the treatment
(Table 2) then appeared to be more effective when the
basal expression was low. Sixteen up-regulated genes were
basally expressed differently [see Additional file 2] and the
others were similarly expressed in the three cell lines
before A23187 treatment.
Down-regulation of 54 genes mostly coding for histones 
and proteins involved in the cell cycle
A significant fold change for repression of the 54 down-
regulated genes mostly occurred in A23187-treated Scott B
lymphoblasts when compared with control B lymphob-
lasts for which repression was of lower amplitude (Table
3). These genes mostly code for histones and for proteins
involved in the progression of the cell cycle. Sets of genes
coding for essential components of the molecular mecha-
nisms involved in movements of organelles, microtubules
or chromosomes and for proteins participating in the cell
cycle at the level of DNA replication, repair and recombi-
nation or nucleotide synthesis were also down-regulated
in A23187-treated cells. Fold change values found in
daughter's cells were either intermediate when compared
to Scott and control B lymphoblasts, or similar to control.
The comparison of the expression levels of these genes in
Scott and daughter's relative to control B lymphoblasts in
the absence of A23187 indicated a reduced basal expres-
sion of a subset of 14 genes in Scott B lymphoblasts [see
Additional file 2]. These genes code for 11 histones and
for CDKN2C, B-myb and thymidine kinase (marked by an
asterisk in Table 3). The other down-regulated genes were
similarly transcribed in the three cell lines in basal culture
conditions.
Independent verification of array findings
To validate the microarray results, we measured the rela-
tive expression of an arbitrarily chosen subset of nine of
the identified genes by real-time quantitative RT-PCR on
new RNA preparations and RT (Fig. 2). Results confirmed
the up-regulation of expression in the presence of A23187
of the genes coding for IFN-inducible gamma 2 (WARS),
argininosuccinate synthetase (ASS) and SIAH2. The
expression differences were of the same range values as
those measured by microarrays analysis for WARS and
SIAH2. Much higher values (for instance a fold change of
91 ± 17 for control B lymphoblasts compared to 12.5
from microarrays) were measured for ASS, demonstrating
that for determining high difference levels the microarrays
data saturate at lower values than those resulting from
quantitative RT-PCR. Determination of mRNA levels
using quantitative RT-PCR for six down-regulated genes
confirmed the fold change values found in the microar-
rays analyses and demonstrated the stronger repression in
Scott B lymphoblasts (Fig. 2). These data provide valida-
tion of the gene expression changes identified by microar-
rays.
Treatment with A23187 alters cell cycle progression
Cell cycle analyses were performed in order to check
whether the decrease in expression of histones and cell
cycle-related genes in A23187-treated cells correlated with
changes in cell cycle progression. The cells continued to
cycle in the presence of 200 nM A23187, although 10%
decrease of populations in S phase was observed, suggest-
ing partial blockade from G1 to S in all of the three cell
lines (Fig. 3). However, cell cycle profiles for A23187-
treated Scott, daughter's and control B lymphoblasts were
differently affected. Scott cells exhibited a 2-fold increase
of cells in G2/M and a very low enhancement of cells in
G1. Conversely, with few changes in the number of cells
in G2/M, the number of control B lymphoblasts in G1 was
increased in the presence of A23187, coinciding with
diminished proportion of cells in S phase. Intermediate
values were found for daughter's B lymphoblasts. There-BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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fore, it appears that treatment with A23187 modifies the
cell cycle with, in Scott cells, a marked increase in G2/M
populations in correlation with blocked progression to
G1.
Discussion
The spontaneous tendency to apoptosis is presumably a
consequence of the still unknown mutation in Scott B
lymphoblasts rather than due to EBV transformation.
Other cases have been described, showing that EBV-trans-
formed B cell lines, independently of viral transformation,
retain the original characters of the B lymphocytes from
which they originate [22]. Indeed, several B lymphoblast
cell lines derived from the patient with Scott syndrome
having provided the cells for this study as well as from the
first described isolated case, all present a spontaneous ten-
dency to apoptosis in culture [12,16,17]. Therefore, we
expected that a better knowledge of the mechanisms
underlying the spontaneous and A23187-induced apop-
tosis in Scott B lymphoblasts would be helpful for the
identification of candidate gene(s) for the mutation(s).
Previous reports on the effects of A23187 on a variety of
cultured cells pointed at apoptosis associated with induc-
tion of early response genes partly dependent only on cas-
pase/Bcl-2 pathways [3,23,24]. However the signaling
pathways controlling A23187-induced cell death are not
known. Several studies have demonstrated that Ca2+ iono-
phores are able to regulate gene transcription in vitro but
the effects varied according to concentration, time course
of the treatment and cell type [25-28]. In this study,
although a possible effect of A23187 treatment for 48 h
on the stability of the various mRNAs cannot be excluded,
the fact that groups of genes were modulated in the same
directions suggests transcriptional regulation. These genes
could be, at least in part, regulated as downstream targets
for early response genes coding for transcription factors or
regulators.
Execution of apoptosis can be regulated by specific tran-
scriptional factors and further modulated by cytokine-
triggered signaling pathways [29]. The cytokines up-regu-
lated in this study are markers of lymphocyte activation
and mediators of inflammation [30-32] and may play a
role in the modification of the B lymphoblasts leading to
cell death. Additional genes up-regulated by A23187-
treatment (see Table 2) code for proteins involved in cell
proliferation [33], metabolism, protein synthesis, transla-
tion, tumor cell proliferation or transcription and may
either promote cell death [23,34] or be markers of pheno-
typic changes. The up-regulated genes mostly appear to be
similarly expressed and modulated in all of the three B cell
lines and one could assume at least a partial role for these
genes in the apoptotic characters of the treated cells
although the importance of a specific gene cannot be
deduced from this study. For instance, all the proteins
coded by the three up-regulated genes analyzed to validate
the microarrays data (WARS, ASS, SIAH2) were all dem-
onstrated in other studies to be either involved in apopto-
sis or anti-proliferation [35,36] and/or markers of
induction by interferon gamma [36,37].
Several mechanisms may simultaneously participate in
the specific effects of A23187 on gene regulation, depend-
ing on the transcription machinery of individual genes.
Our study further demonstrated that the treatment of
Scott B lymphoblasts with A23187 provokes a down-reg-
ulation of a restricted set of 54 different genes. The tran-
scription level of these genes was repressed more than
two-fold in A23187-treated Scott B lymphoblasts and also
decreased, although to lower extent, in daughter's and
control B lymphoblasts.
Interestingly, at least 31 out of these 54 genes code for
proteins involved in the formation of essential complexes
during the onset of cell cycle or in cell cycle progress, and
13 of them code for histones. Genes expressing positive
and negative regulators of the cell cycle were repressed,
suggesting a complex effect of the treatment on cycle pro-
gression. Among the repressed genes are those coding for
the cyclin-dependent serine-threonine kinase cdc2 and
the subunit cyclins A and B, each being involved in the
control of entry into mitosis and cell cycle advancement
[38,39]. Remarkably, the gene encoding the cyclin-selec-
tive ubiquitin carrier, which participates in the destruction
of cyclins A and B promoting exit from mitosis into G1 of
the next cell cycle [40], is also repressed. Several down-reg-
ulated genes, coding for serine/threonine kinases (STKs in
Table 3), are implicated in the segregation of chromo-
somes during mitotic cell division [41]. Other genes code
for transcription factors or regulators, such as B-myb,
which are important for chromosome segregation [42].
Decrease of histones H1.2, 3 H2A and 9 H2B expression is
a characteristic feature observed in A23187-treated cells,
including daughter's and control B lymphoblasts. His-
tones, of which genes are transcriptionally modulated as
the cell cycle progresses, play key roles in the structural
and transcriptional properties of the chromatin [43]. If
the repressed genes are regulated at the transcriptional
level in a coordinated fashion, one may hypothesize that
common promoter elements may direct the observed pat-
tern of regulation. Remarkably, expression of a large por-
tion of the down-regulated genes is controlled by
member(s) of the E2F family transcription factors. Among
these genes are histones, cyclins A and B, B-myb, Cdc2, Bub1,
thymidine kinase,  dihydrofolate reductase, top2,  Flap
endonuclease1 [44]. E2F-DP1 heterodimers, essential for
the G1/S phase transition bind to promoter elements and
are negatively regulated by the hypo-phosphorylatedBMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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Table 3: Fold change of repressed gene expression in B lymphoblasts treated with ionophore A23187. Genes listed here showed a 
decreased gene expression (2-fold or more) in at least one of the three B lymphoblasts cultured for 48 h with 200 nM A23187. Data are 
fold changes calculated from hybridization values in treated versus non treated cells for each one of the B lymphoblasts respectively 
(see fold-changes < 0.5 in additional file 1 corresponding to <-1/0.5 in this table). For each functional group, the genes were ordered by 
using a program for gene clustering. *Fourteen genes are basally under-expressed in Scott B lymphoblasts compared to control cells.
Accession no. control daughter's Scott Gene definition
Histones
X57129 -3.79 -3.59 -6.54 H1.2*
X00088 -6.80 -3.41 -3.62 H2b/r*
Z80779 -4.49 -2.11 -2.31 H2B/g*
Z80782 -2.96 -2.42 -3.41 H2B/k*
Z83336 -2.98 -2.12 -2.08 H2B/d*
L19779 -2.97 -2.01 -1.66 H2A.2*
AJ223352 -2.57 -1.71 -2.57 H2B/a*
Z83740 -2.92 -1.69 -1.83 H2B/c*
U91328 -2.81 -1.31 -1.65 H2A-like protein*
AJ223353 -3.12 -1.92 -1.27 H2B/b
Z83738 -3.08 -1.88 -1.98 H2B/e*
Z80780 -3.06 -1.84 -2.85 H2B/h*
X14850 -1.45 -1.40 -3.20 H2A.X
Cell cycle and proliferation
AF041248 -2.58 -1.78 -1.84 CDKN2C*
X04757 -2.53 -2.55 -1.31 alpha-tubulin
J00139 -2.35 -2.35 -5.23 dihydrofolate reductase
U05340 -3.12 -2.44 -6.60 p55CDC
U37426 -2.07 -1.41 -5.10 HKSP
AF067656 -2.18 -1.26 -4.08 ZW10 interactor
AF011468 -2.20 -1.97 -6.05 BTAK
M25753 -2.13 -1.91 -7.30 cyclin B
Z36714 -2.20 -1.94 -3.74 cyclin F
D55716 -2.04 -1.57 -3.25 P1cdc47
D14678 -1.92 -2.05 -3.63 kinesin-related protein
X76771 -1.85 -1.17 -2.75 flap endonuclease-1
X62534 -1.38 -1.15 -3.20 HMG-2
X54942 -1.43 -1.48 -2.79 ckshs2
L37747 -1.65 -1.63 -2.84 lamin B1
L25876 -1.91 -1.69 -3.63 CIP2
D14657 -1.82 -1.27 -3.35 mRNA for KIAA0101 (p15-PAF)
L16991 -1.92 -1.78 -4.08 CDC8
AB024704 -1.76 -1.86 -4.60 fls353
X13293 -1.93 -1.69 -5.74 B-myb*
X05360 -1.84 -1.04 -4.12 CDC2
X51688 -1.62 1.05 -5.23 cyclin A
U63743 -2.00 -1.96 -6.59 centromere-associated kinesin
AF017790 -1.85 -1.55 -4.40 retinoblastoma-associated protein
AF004022 -1.92 -1.62 -5.11 protein kinase STK12
U14518 -2.00 -1.65 -5.02 CENP-A
U30872 -1.68 -1.49 -5.00 mitosin
J04088 -1.70 -1.22 -5.16 top2
AF035933 -1.80 -1.21 -4.54 protein kinase SSK1
K02581 -1.91 -1.63 -5.02 thymidine kinase*
U73379 -1.79 -1.66 -8.96 cyclin-selective ubiquitin carrier
Micellaneous
U49184 -11.24 -6.64 -4.10 occludin
L02950 -5.26 -4.49 -3.85 mu-crystallin
AB047079 -2.20 -2.54 -4.21 IRE1b
U29343 -2.11 -1.58 -4.07 hyaluronan receptor
D13633 -2.21 -1.72 -6.35 putative gene KIAA0008
AF057557 -1.75 -3.43 -3.45 TOSO
X59350 -1.95 -1.06 -3.43 CD22
AF053641 -1.46 -1.45 -2.65 CSE1
AF274943 -1.20 -1.06 -2.45 PNAS-18
M91438 -1.18 -1.02 -3.41 HUSI-IIBMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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retinoblastoma protein Rb [45]. A role for E2F in regulat-
ing gene expression of several histones subtypes correlates
with the presence of consensus sequences for E2F binding
in the shared H2A/H2B  promoters [46]. However, the
location of these sequences in the promoter domain is
closer to the H2A side rather than to that of H2B (corre-
sponding to most of the histones genes repressed in this
study). This observation, together with the fact that only a
restricted fraction of the known E2F target genes were
repressed, suggests complex regulatory mechanisms for
transcriptional regulation of genes down-regulated in the
presence of A23187.
The data suggest a link between G0/G1 or G2/M cell cycle
arrests and apoptosis. Similar relationships were previ-
ously demonstrated through various studies (see [47] and
as shown for the effect of several anticancer agents [48-
50]). Furthermore, the individual inhibition or knock-
down of several genes repressed in the presence of
A23187, such as top2 or lamin B1, was shown to induce
apoptosis in HeLa cells [47,51,52]. Our results suggest
that the down-regulation of cell cycle genes explains, at
least partly, the apoptogenic effect of A23187. Although
the analysis of the cell cycle phases did not show signifi-
cant differences between the three B cell lines under basal
conditions, A23187 treatment clearly changed the cell
cycle profiles for all cell types. The presence of A23187 in
culture medium diminished the transcription of genes
important for progression of the cell cycle at the G1 phase
correlating with an increase of cells in G1 and decrease of
S phase cells. This was observed in all cell types, correlat-
ing with the down-regulation of cell cycle genes, although
with lower change levels in daughter's cells and controls.
Moreover, significant blockade of cells in G2/M phase was
mainly observed for Scott and (at a lesser extent) daugh-
ter's B lymphoblasts.
Networks linking signaling and cell proliferation have
now been widely described, connecting for instance Ras
effector/extracellular signal-regulated kinase pathway
with the Rb/E2F pathway, controlling either cell prolifer-
ation, differentiation, cell growth arrest or apoptosis [53].
These observations suggest that the expression pattern of
the genes down-regulated by A23187 is associated with
the apoptotic tendency of the cultured Scott B lymphob-
lasts. The present work leads to the hypothesis that a
mutation in Scott cells would reside in a signaling path-
way component shared by the membrane remodeling
process and the transcriptional regulation of a subset of
cell cycle genes upon addition of the Ca2+ ionophore.
Conclusion
The apoptogenic effect due to the addition to cultured
cells of 200 nM A23187 for 48 hours correlates with an
overall pattern of gene regulation involving at least a hun-
dred genes and demonstrating the coordinated regulation
of sets of them. Analysis of gene regulation upon treat-
ment also represented a new approach to understand the
still unexplained defective mechanism(s) in Scott cells.
The results orientate the future work toward the explora-
tion of a signaling defect in Scott B lymphoblasts
upstream of the transcriptional machinery for genes par-
ticipating in cell cycle progress and down-regulated with
the treatment.
Methods
Cell lines
The cases of the propositus with Scott syndrome and of
her daughter have been previously described and familial
study has suggested a homozygous status for the proposi-
tus [13]. Control B lymphocytes were obtained from con-
senting and informed volunteers unrelated to the patient.
All B lymphoblasts used in this study were B lymphocytes
transformed in our laboratory by EBV-infection into pro-
liferating cell lines as already reported [13]. The Scott phe-
notype, i.e. a lack of exposure of procoagulant
phosphatidylserine due to defective membrane remode-
ling, was constantly observed in independently EBV-
infected B cells from the propositus [13]. The B lymphob-
lasts derived from the propositus' daughter (daughter's B
lymphoblasts in this study) exhibited in vitro functional
properties coinciding with heterozygous status, although
this individual denied any hemorrhagic tendency [13]. B
lymphoblasts were routinely seeded at 2 × 105 cells/ml
and expanded to 6 × 105 cells/ml in X-VIVO15 culture
medium (BioWhittaker, Cambrex Bio Science, Verviers,
Belgium, [Ca2+]free = 1.8 mM), without any other additive.
Culture conditions in the presence of Ca2+ ionophore 
A23187
The B lymphoblasts (8 × 107 cells) were seeded at 5 × 105
cells/ml in X-VIVO15 medium. To treat the cells, A23187
(200 nM final concentration, Calbiochem, La Jolla, CA)
was added to the cultures four hours later. Treated and
non-treated cells were further cultured for the indicated
times before harvesting.
Assessment of apoptosis
Detection and quantification of apoptosis were per-
formed on 6 × 105 cells, washed twice with Hanks' bal-
anced salt solution (Sigma-Aldrich), and diluted in 300 μl
of the same solution supplemented with 1 mM CaCl2.
Fluorescein isothiocyanate (FITC)-Annexin V solution
(BD Biosciences, Pharmingen) was added to 5% vol/vol.
The cells were then incubated for 20 min at room temper-
ature before analysis to quantify the apoptotic cells that
expose PS with the CELL Quest software using a FACSscan
flow cytometer (BD Biosciences).BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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Cell cycle analysis
For cell cycle studies, 3 × 106 cells were collected and incu-
bated in the dark at 4°C for 20 min in 500 μl of phosphate
buffer saline supplemented with 0.1% Triton X-100, 0.5
mg/ml RNase A (type I, Sigma) and 50 μg/ml propidium
iodide (PI, CN Biosciences, Nottingham, UK). Data acqui-
sition were performed by flow cytometry analysis by gat-
ing on an appropriate area to exclude cell debris and
aggregate with the CELLQuest software using a FACSscan
flow cytometer (BD Biosciences, San Jose, CA, USA).
Quantification of cells in the different phases of the cycle
was then performed using the ModFit LT™ software (Ver-
ity Software House Inc., Topsham, ME, USA). Results are
expressed as percentage of cells in each phase of the cell
cycle.
RNA extraction, cRNA preparation and microarray 
hybridization
B lymphoblasts were cultured for 48 h in the presence or
absence of 200 nM A23187. Total RNA from cultured cells
was isolated for double-stranded cDNA synthesis using
Trizol™ reagent (Invitrogen Ltd, Paisley, UK) according to
the manufacturer's instructions. RNA was further purified
with RNeasy columns (Qiagen, Hilden, Germany). Ten μg
of total RNA were subjected to first strand cDNA synthesis
reaction using an oligo(dT)-primer with a T7-promoter
sequence added to the 5'-end (Superscript Choice System,
Invitrogen Ltd). After second-strand synthesis, double-
stranded cDNA was purified by phenol/chloroform
extraction, precipitated and diluted in nuclease-free water.
Biotin-labeled cRNA was made by in vitro transcription
using ENZO Bioarray High Yield Transcription kit
(Affymetrix Inc, Santa Clara, CA, USA). The resulting
Quantitative RT-PCR validation for a subset of genes differ- entially expressed by treatment with A23187 Figure 2
Quantitative RT-PCR validation for a subset of genes 
differentially expressed by treatment with A23187. 
RTs were performed with new RNA prepared from the 
treated and untreated cell lysates. For each PCR experiment, 
RT samples were analyzed at least in triplicate for the 
expression of a gene in parallel with GAPDH and 18S rRNA as 
described in Methods. Results are means ± SD from two 
independent PCR experiments with different RTs (each ana-
lyzed at least in triplicate) for the up-regulated genes and 
three independent PCR experiments for the down-regulated 
genes. The fold changes in expression level, i.e. 2-ΔΔCT for the 
up-regulated genes calculated as described in Methods and -
1/2-ΔΔCT for the down-regulated genes (to compare with the 
values given in Table 3), are represented on a logarithmic 
scale. Some of the gene symbols listed in Table 2 and 3 have 
been recently renamed by Affymetrix [54] and the latest 
symbols were used for ordering the Assays-on-Demand. 
WARS: IFN-inducible gamma 2, Ac. N° X59892; ASS: 
argininosuccinate synthetase, Ac. N° X01630; SIAH2, Ac. N° 
U76248; CDC20: p55CDC, Ac. N° U05340; CCNB1: cyclin 
B, Ac. N° M25753; AURKB: protein kinase STK 12, Ac. N° 
AF004022; UBE2C: cyclin-selective ubiquitin carrier, Ac. N° 
U73379; H2H2AA: H2A.2, Ac. N° L19779; H1H2BM: H2B/e, 
Ac. N° Z83738.
Effect of A23187 on B lymphoblasts cell cycle Figure 3
Effect of A23187 on B lymphoblasts cell cycle. The B 
lymphoblasts cultured in the absence or presence of 200 nM 
A23187 for 48 hours were stained with PI and analyzed for 
the proportion of cells in the different phases of the cycle by 
flow cytometry as described in Methods. Two independent 
experiments were performed with each one of five cell lines 
(two Scott B lymphoblasts independently immortalized from 
the patient's lymphocytes, one daughter's and two control 
cell lines from unrelated individuals). Data are means ± SD 
from the four independent experiments for Scott and con-
trol B lymphoblasts respectively and the two experiments for 
daughter's cells. For a given phase of the cell cycle and a cell 
type, P reflects the statistical differences between the percent 
of cells in the presence versus absence of A23187. 
*P = 0.0038, #P = 0.0016, ✝P = 0.0344, ✰P = 0.004,
◆P = 0.0134.BMC Genomics 2005, 6:146 http://www.biomedcentral.com/1471-2164/6/146
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cRNA was fragmented at 94°C for 35 minutes in 40 mM
Tris-acetate buffer, pH 8.1, 100 mM K-acetate and 30 mM
Mg-acetate. Human genome U95Av2 GeneChip® micro-
array (see the updated list in [54]) was used to analyze
gene expression patterns. For hybridization with Gene-
Chip®, 12 μg of fragmented cRNA was incubated with 50
pM control oligonucleotide B2 (Affymetrix Inc.), 1X
eukaryotic hybridization control (Affymetrix Inc.), 0.1
mg/ml herring sperm DNA and 0.5 mg/ml acetylated BSA
and 1X hybridization buffer according to the manufac-
turer's instructions for 16 to 18 h at 45°C. Washing and
staining were performed in Affymetrix GeneChip® Fluidics
Station using Affymetrix antibody staining and washing
protocol. GeneChip® microarrays were scanned with Agi-
lent Gene Array (Affymetrix Inc.) scanner (100% PMT set-
tings). Results for a given sample originate from two
independent sample preparations, in vitro transcriptions
and hybridization reactions performed in order to avoid
any bias due to variations in sample treatment.
Analysis of hybridization data
Scanned images were analyzed using Microarray Suite 4.0
(Affymetrix Inc.), which assigns an intensity that is a
measure of the corresponding transcript abundance. Rep-
licates were combined by computing the median of the
replicate intensity. For each Probe Set ID, the expression
ratios were obtained using both intensity and noise data
through the PFOLD algorithm [55]. This provides an esti-
mate of the expression ratio and also a P-value, which
quantifies its statistical significance. All statistics and
graphics related to Affymetrix analysis were performed
using the GECKO software [21]. Ratios determining the
fold changes in gene expression due to A23187 treatment
were determined for each cell line, ie: Scott, daughter's
and control B lymphoblasts. All further analyses were per-
formed with genes displaying a 2-fold change or more in
expression level and a P-value <0.02 for at least one of the
three cell lines (see additional file 1). Data are deposited
in NCBI's GEO (Gene Expression Omnibus site) [56] with
accession N° GSE1028.
Quantitative RT-PCR
Reverse transcription (RT) followed by quantitative real-
time polymerase chain reaction (quantitative RT-PCR)
was performed on new RNA preparations of the B lym-
phoblasts lysates to validate the microarray data. RT was
performed with 4.5 μg of total RNA (100 μl final reaction)
using the High-Capacity cDNA Archive Kit (Applied Bio-
systems, Foster City, CA). Quantitative PCR was per-
formed using an ABI Prism 7000 Sequence Detector
(Applied Biosystems). PCR was performed with 5 μl of 10
times diluted RT samples mixed in 96-well optical reac-
tion plates with 20 μl of a solution containing the TaqMan
Universal PCR master mix and a TaqMan Assay-on-
Demand (Applied Biosystems) according to the manufac-
turer's instructions. The TaqMan Assays-on-Demand
include the primers and a fluorescent TaqMan (6-FAM
dye-labeled) probe allowing the specific amplification of
a cDNA and its quantification via the determination of the
threshold cycle (CT) value. The thermal cycling conditions
were: 50°C for 2 min and 95° for 10 min, followed by 40
cycles of 95° for 15 s and 60° for 1 min. For a PCR exper-
iment, each RT sample was analyzed at least in triplicate
for every analyzed cDNA. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, for which gene expression was
not regulated by A23187 treatment) and 18S rRNA were
amplified from the same RT in separate reactions to nor-
malize the results. The PCR experiments were repeated
three times for the genes down-regulated by treatment
with A23187 and twice for the up-regulated genes. Rela-
tive quantification of gene expression was carried out
using the 2-ΔΔCT method . The average (CT) value for
GAPDH or 18S was subtracted from the average (CT)
value for the analyzed cDNA (ΔCT). Difference in (ΔCT)
values between A23187 treated and untreated samples (-
ΔΔCT) were used to calculate the relative change in gene
expression ( = 2-ΔΔCT).
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